16:50:07 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-30 Kvartalsrapport 2024-Q2
2024-04-29 Årsstämma 2024
2024-04-11 Ordinarie utdelning MONSO 0.00 DKK
2024-03-06 Bokslutskommuniké 2023
2023-09-07 Kvartalsrapport 2023-Q2
2023-04-13 Ordinarie utdelning MONSO 0.00 DKK
2023-04-12 Årsstämma 2023
2023-03-08 Bokslutskommuniké 2022
2022-12-20 Extra Bolagsstämma 2022
2022-08-31 Kvartalsrapport 2022-Q2
2022-04-07 Ordinarie utdelning MONSO 0.00 DKK
2022-04-06 Årsstämma 2022
2022-03-09 Bokslutskommuniké 2021
2021-11-16 Extra Bolagsstämma 2021
2021-08-26 Kvartalsrapport 2021-Q2
2021-04-15 Ordinarie utdelning MONSO 0.00 DKK
2021-04-14 Årsstämma 2021
2021-03-10 Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorInformationsteknik
IndustriProgramvara
Monsenso är verksamt inom IT-sektorn. Bolaget är specialiserat inom tillhandahållandet av digitala uppföljningssystem för vård och omsorg, samt sjukhus. Lösningarna är mjukvarubaserade och används huvudsakligen för uppföljning av patienters hälsotillstånd, samt för intern bevakning och analys. Störst verksamhet återfinns inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.
2021-04-23 15:49:27

23.4.2021 15:49:26 CEST | Monsenso | Company Announcement

Company announcement no. 10-2021

Copenhagen, 2021.04.23

The Board of Directors of Monsenso A/S hereby announces the decision to issues warrants with the aim of ensuring that shareholders, management, and employees have uniform interests and that everyone makes a special effort to create value in the company and maintain the company's management and employees.

The warrant program includes employees, hereunder management, who are in a non-terminated position and who were employed on January 1st, 2021.

The vesting period for the warrants is 36 months from May 1st, 2021 to April 30th, 2024, but only if the recipient is still employed by the company. Unexercised warrants expire on August 31st, 2028. DKK 440,000 warrants have been granted, giving the right to subscribe for a nominal DKK 44,000 shares in the company.

The Board of Directors has set the exercise price at DKK 5.86 per warrant, which is less than the market price and in accordance with § 5.3 of the company's articles of association. The value of each warrant can be calculated at DKK 8.40 based on an interest rate of 2% and a volatility of the company's shares of 93% (using the Black-Scholes formula).

The warrant holder shall not pay any compensation for the granting of the warrants. The vested warrants can be exercised twice a year after the publication of the company's annual and half-yearly report in an exercise window of pt. 2 weeks.

Monsenso's share capital amounts to a nominal value of DKK 1,339,197.50 divided into 13,391,975 shares of DKK 0.10.

 

Any inquiries regarding this notice should be directed to:

Monsenso

Chairman of the board
Maria Hjorth
Tel. +45 25 55 63 39
E-mail: maria.hjorth@gmail.com

CEO
Thomas Lethenborg
Tlf. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Certified Adviser:

Norden CEF ApS
John Norden
Tlf. +45 20 72 02 00
E-mail: jn@nordencef.dk

About Monsenso

Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit  www.monsenso.com

Attachments